Suppr超能文献

为纳米神经医学启用纳米材料、纳米制造和细胞技术。

Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines.

作者信息

Mallapragada Surya K, Brenza Timothy M, McMillan JoEllyn M, Narasimhan Balaji, Sakaguchi Donald S, Sharma Anup D, Zbarska Svitlana, Gendelman Howard E

机构信息

Department of Chemical and Biological Engineering, Iowa State University, Ames, IA USA.

Department of Chemical and Biological Engineering, Iowa State University, Ames, IA USA.

出版信息

Nanomedicine. 2015 Apr;11(3):715-29. doi: 10.1016/j.nano.2014.12.013. Epub 2015 Jan 31.

Abstract

Nanoparticulate delivery systems represent an area of particular promise for nanoneuromedicines. They possess significant potential for desperately needed therapies designed to combat a range of disorders associated with aging. As such, the field was selected as the focus for the 2014 meeting of the American Society for Nanomedicine. Regenerative, protective, immune modulatory, anti-microbial and anti-inflammatory products, or imaging agents are readily encapsulated in or conjugated to nanoparticles and as such facilitate the delivery of drug payloads to specific action sites across the blood-brain barrier. Diagnostic imaging serves to precisely monitor disease onset and progression while neural stem cell replacement can regenerate damaged tissue through control of stem cell fates. These, taken together, can improve disease burden and limit systemic toxicities. Such enabling technologies serve to protect the nervous system against a broad range of degenerative, traumatic, metabolic, infectious and immune disorders. From the clinical editor: Nanoneuromedicine is a branch of nanomedicine that specifically looks at the nervous system. In the clinical setting, a fundamental hurdle in nervous system disorders is due to an inherent inability of nerve cells to regenerate after damage. Nanotechnology can offer new approaches to overcome these challenges. This review describes recent developments in nanomedicine delivery systems that would affect stem cell repair and regeneration in the nervous system.

摘要

纳米颗粒递送系统是纳米神经医学中一个特别有前景的领域。它们对于旨在对抗一系列与衰老相关疾病的急需疗法具有巨大潜力。因此,该领域被选为2014年美国纳米医学学会会议的重点。再生、保护、免疫调节、抗菌和抗炎产品或成像剂很容易被包裹在纳米颗粒中或与纳米颗粒结合,从而促进药物有效载荷穿过血脑屏障输送到特定作用部位。诊断成像有助于精确监测疾病的发作和进展,而神经干细胞替代可以通过控制干细胞命运来再生受损组织。这些综合起来,可以减轻疾病负担并限制全身毒性。此类赋能技术有助于保护神经系统免受多种退行性、创伤性、代谢性、感染性和免疫性疾病的侵害。临床编辑评论:纳米神经医学是纳米医学的一个分支,专门研究神经系统。在临床环境中,神经系统疾病的一个基本障碍是神经细胞在受损后固有的再生能力不足。纳米技术可以提供新的方法来克服这些挑战。本综述描述了纳米医学递送系统的最新进展,这些进展将影响神经系统中的干细胞修复和再生。

相似文献

1
Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines.
Nanomedicine. 2015 Apr;11(3):715-29. doi: 10.1016/j.nano.2014.12.013. Epub 2015 Jan 31.
2
Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.
Nanomedicine. 2015 Apr;11(3):751-67. doi: 10.1016/j.nano.2014.12.014. Epub 2015 Jan 31.
3
Nanomaterial applications in multiple sclerosis inflamed brain.
J Neuroimmune Pharmacol. 2015 Mar;10(1):1-13. doi: 10.1007/s11481-015-9588-y. Epub 2015 Jan 24.
5
Recent advances in nanomaterials for neural applications: opportunities and challenges.
Nanomedicine (Lond). 2023 Nov;18(26):1979-1994. doi: 10.2217/nnm-2023-0261. Epub 2023 Dec 11.
6
Nanotechnology for neurodegenerative disorders.
Nanomedicine. 2012 Sep;8 Suppl 1:S51-8. doi: 10.1016/j.nano.2012.05.007. Epub 2012 May 26.
7
Nanomedicine and drug delivery.
Med Clin North Am. 2007 Sep;91(5):863-70. doi: 10.1016/j.mcna.2007.05.005.
8
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
J Nanobiotechnology. 2016 May 26;14(1):39. doi: 10.1186/s12951-016-0193-x.
9
Overcoming the Blood-Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases.
Adv Mater. 2018 Nov;30(46):e1801362. doi: 10.1002/adma.201801362. Epub 2018 Jul 31.
10
Nanotechnology and multipotent adult progenitor cells in Reparative Medicine: therapeutic perspectives.
Einstein (Sao Paulo). 2018 Nov 29;16(4):eRB4587. doi: 10.31744/einstein_journal/2018RB4587.

引用本文的文献

1
Current and future state of the management of Hirschsprung disease.
World J Pediatr Surg. 2025 Mar 31;8(1):e000860. doi: 10.1136/wjps-2024-000860. eCollection 2025.
2
Agrin Inhibition in Enteric Neural Stem Cells Enhances Their Migration Following Colonic Transplantation.
Stem Cells Transl Med. 2024 May 14;13(5):490-504. doi: 10.1093/stcltm/szae013.
4
Directed Assembly of Nanomaterials for Making Nanoscale Devices and Structures: Mechanisms and Applications.
ACS Nano. 2022 Nov 22;16(11):17641-17686. doi: 10.1021/acsnano.2c07910. Epub 2022 Oct 21.
6
Disentangling Mitochondria in Alzheimer's Disease.
Int J Mol Sci. 2021 Oct 26;22(21):11520. doi: 10.3390/ijms222111520.
7
110 Anniversary: Nanoparticle mediated drug delivery for the treatment of Alzheimer's disease: Crossing the blood-brain barrier.
Ind Eng Chem Res. 2019;58(33):15079-15087. doi: 10.1021/acs.iecr.9b02196. Epub 2019 Jul 23.
8
Biodegradable polyanhydride-based nanomedicines for blood to brain drug delivery.
J Biomed Mater Res A. 2018 Nov;106(11):2881-2890. doi: 10.1002/jbm.a.36477. Epub 2018 Oct 26.
9
Neuronal protection against oxidative insult by polyanhydride nanoparticle-based mitochondria-targeted antioxidant therapy.
Nanomedicine. 2017 Apr;13(3):809-820. doi: 10.1016/j.nano.2016.10.004. Epub 2016 Oct 19.
10
Neuropharmacologic Approaches to Restore the Brain's Microenvironment.
J Neuroimmune Pharmacol. 2016 Sep;11(3):484-94. doi: 10.1007/s11481-016-9686-5. Epub 2016 Jun 28.

本文引用的文献

1
Nanopharmaceuticals (part 1): products on the market.
Int J Nanomedicine. 2014 Sep 15;9:4357-73. doi: 10.2147/IJN.S46900. eCollection 2014.
2
Non-covalently functionalized carbon nanostructures for synthesizing carbon-based hybrid nanomaterials.
J Nanosci Nanotechnol. 2014 Feb;14(2):1425-40. doi: 10.1166/jnn.2014.9048.
3
Biological applications of nanobiotechnology.
J Nanosci Nanotechnol. 2014 Jan;14(1):1007-17. doi: 10.1166/jnn.2014.8748.
4
Neurons on nanotopographies: behavioral responses and biological implications.
J Nanosci Nanotechnol. 2014 Jan;14(1):513-21. doi: 10.1166/jnn.2014.8764.
6
Guiding stem cell differentiation into oligodendrocytes using graphene-nanofiber hybrid scaffolds.
Adv Mater. 2014 Jun 11;26(22):3673-80. doi: 10.1002/adma.201400523. Epub 2014 Mar 26.
7
Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles.
Eur J Pharm Biopharm. 2014 May;87(1):19-29. doi: 10.1016/j.ejpb.2014.02.013. Epub 2014 Mar 4.
8
Nanodrugs: pharmacokinetics and safety.
Int J Nanomedicine. 2014 Feb 20;9:1025-37. doi: 10.2147/IJN.S38378. eCollection 2014.
9
The promise of nanoneuromedicine.
Nanomedicine (Lond). 2014 Feb;9(2):171-6. doi: 10.2217/nnm.14.17.
10
Nanoscale drug delivery systems and the blood-brain barrier.
Int J Nanomedicine. 2014 Feb 7;9:795-811. doi: 10.2147/IJN.S52236. eCollection 2014.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验